---
title: IQVIA vs Parexel
slug_a: iqvia
slug_b: parexel
site: cro
review_signal_gate: closed
canonical_path: /compare/iqvia/parexel
---

# IQVIA vs Parexel

Side-by-side profile data from each company listing on this directory.

## IQVIA

- Profile: [/companies/iqvia](/companies/iqvia)

IQVIA — IQVIA is a global life sciences and healthcare company providing data, expertise, AI, analytics, and technology solutions to support clinical development and improve patient outcomes.

Services: 26. Modalities: 6. Indications: 14. Locations: 3. Certifications: 0. The strongest documented coverage currently appears in services (26).

### Services

- Bioanalysis
- Immunogenicity Assays (ADA / NAb)
- Biomarker Assays
- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Central Laboratory Services
- Clinical Imaging Core Lab
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- Japan PMDA Regulatory Strategy
- China NMPA Regulatory Strategy
- Translational Research
- Immunology & Inflammation Services
- Oncology Specialty Services
- CNS Specialty Services
- Cardiovascular & Metabolic Specialty Services
- Bioinformatics & Data Science

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Cell Therapy
- Gene Therapy
- Vaccine

### Indications

- Oncology
- Immunology
- Neurology
- Psychiatry
- Metabolic
- Cardiovascular
- Infectious Disease
- Rare Disease
- Respiratory
- Dermatology
- Ophthalmology
- Gastroenterology
- Nephrology
- Women's Health

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV
- Real-World Evidence (RWE) / Registries

### Sourcing models

- Full-Service Outsourcing (FSO)
- Functional Service Provider (FSP)

## Parexel

- Profile: [/companies/parexel](/companies/parexel)

Parexel — Parexel is a comprehensive CRO offering end-to-end biopharmaceutical development services spanning portfolio optimization, early development, integrated clinical development, regulatory approval, and lifecycle value substantiation.

Services: 17. Modalities: 3. Indications: 12. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (17).

### Services

- Biomarker Assays
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- Japan PMDA Regulatory Strategy
- China NMPA Regulatory Strategy
- Translational Research
- Genomics & Sequencing Services

### Modalities

- Cell Therapy
- Gene Therapy
- Vaccine

### Indications

- Oncology
- Immunology
- Neurology
- Psychiatry
- Metabolic
- Cardiovascular
- Infectious Disease
- Rare Disease
- Respiratory
- Ophthalmology
- Gastroenterology
- Women's Health

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV
- Real-World Evidence (RWE) / Registries

### Sourcing models

- Functional Service Provider (FSP)